However, the hypothesis that BCP-induced NF-ĸB inhibition might exert beneficial effects in arthritis by negatively modulating other inflammatory signaling, such as Wnt5a [31], cannot at this moment ruled out. The gene discussed is WNT5A; the disease is Arthritis.